Showing results (1-10 of 38) with videos related to
Sort By:
Pageof 4
Current Opinion in Cardiology|June 29, 2023
Monitoring treatment with cardiac myosin inhibitors in symptomatic obstructive hypertrophic cardiomyopathySafia Chatur, Sheila M HegdeThe Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|June 9, 2016
Inhibition of vascular endothelial growth factor reduces cardiac allograft vasculopathySafia Chatur, Brian W-C Wong, Jon M Carthy, et al.Journal of the American Heart Association|May 16, 2019
Incidence of Syncope During Pregnancy: Temporal Trends and OutcomesSafia Chatur, Sunjidatul Islam, Linn E Moore, et al.European Journal of Heart Failure|October 1, 2022
Sacubitril/valsartan and loop diuretic requirement in heart failure with preserved ejection fraction in the PARAGON-HF trialSafia Chatur, Brian L Claggett, Orly Vardeny, et al.European Journal of Heart Failure|January 23, 2025
Canagliflozin reduces oral loop diuretic intensification in patients with type 2 diabetes: A participant-level pooled analysis of the CANVAS and CREDENCE trialsSafia Chatur, Muthiah Vaduganathan, Robert A Fletcher, et al.American Heart Journal|February 23, 2025
Reminders embedded in PCI reports to optimize discharge diabetes mellitus care (REMIND-DM): Rationale, design, and baseline characteristicsSafia Chatur, Milan Seth, Mary Casey, et al.Journal of Cardiac Failure|September 30, 2025
Expanded Results from a Dedicated Guideline-Directed Medical Therapy ClinicLaura P Cohen, Charlotte Paquette, Michelle Vassilopoulos, et al.Journal of the American College of Cardiology|February 22, 2023
Variation in Renal Function Following Transition to Sacubitril/Valsartan in Patients With Heart FailureSafia Chatur, Brian L Claggett, Finnian R McCausland, et al.Journal of the American College of Cardiology|June 2, 2010
RVX-208: a small molecule that increases apolipoprotein A-I and high-density lipoprotein cholesterol in vitro and in vivoDana Bailey, Ravi Jahagirdar, Allan Gordon, et al.European Journal of Heart Failure|April 10, 2026
Spironolactone, Early Acute eGFR Changes, and Clinical Outcomes in Patients with Heart Failure with Preserved Ejection Fraction: Insights from TOPCAT AmericasIris E Beldhuis, Brian L Claggett, Brendon L Neuen, et al.Pageof 4